RAD51 and tongue squamous cell carcinoma: We also compared RAD51 expression in oral mucosa epithelial cells (OMECs), keratinocytes, and tongue squamous cell carcinoma cells (TSCCs) to provide a theoretical basis for the clinical use of RAD51 as a prognostic biomarker for oral cancer.